PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. Psychoactive medications treat the illness by rewiring the brain through contemplation and a change of perception in combination with psychotherapy vs. Standard of care (SSRI’s, SNRI’s, MAOI’s, NDRI’s, etc…) which just chemically treat symptoms. Working in partnership with Miami University utilizing a proprietary platform technology to biologically synthesize psilocybin and other targeted next-generation active compounds in Psilocybe Cubensis and other fungi and plants.
TSXV: #PSYB OTCQB: #PSYBF
Company Details
- Address
- 4400 W Sample Rd, Suite 138,united States
- Industry
- Biotechnology
- Website
- https://www.psybiolife.com/
- HQ
- Coconut Creek, Florida
Psybio Therapeutics Corp Questions
Psybio Therapeutics Corp's website is https://www.psybiolife.com/
Psybio Therapeutics Corp's LinkedIn profile is https://www.linkedin.com/company/psybiolife
Psybio Therapeutics Corp's industry is
Biotechnology
Psybio Therapeutics Corp's top competitors are
Psyence Group,
Myosin Therapeutics Inc.,
Neumora,
Filament Health,
Tactogen,
Agile Therapeutics,
Graymatters Health,
Cybin Inc,
Sensorium Therapeutics,
Tryp Therapeutics.
Psybio Therapeutics Corp's categories are Biotechnology
